Pms21 - Budget Impact Model of Inclusion of Tofacitinib for the Treatment of Rheumatoid Arthritis in France
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1735
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV